Dr. Scala is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2333 Buchanan St
# Level
San Francisco, CA 94115Phone+1 415-600-3600
Summary
- Lawrence Scala, MD, is a radiation oncologist based in San Francisco, CA, specializing in prostate cancer treatment. He completed his residency in radiation oncology at California Pacific Medical Center in 2011 and undertook an internship in internal medicine at Atlantic Health System/Overlook Medical Center. He graduated from Rutgers New Jersey Medical School in 2006. Dr. Scala has been a staff physician at Kaiser Permanente and Kaiser Permanente Santa Clara Medical Center since 2012. His published works include research on intraoperative high-dose-rate radiotherapy for head and neck cancer and a dosimetric analysis related to prostate cancer treatment, both of which have been cited multiple times.
Education & Training
- California Pacific Medical CenterResidency, Radiation Oncology, 2007 - 2011
- Atlantic Health System/Overlook Medical CenterInternship, Internal Medicine, 2006 - 2007
- Rutgers New Jersey Medical SchoolClass of 2006
Certifications & Licensure
- CA State Medical License 2008 - 2026
- NY State Medical License 2011 - 2013
- PA State Medical License 2011 - 2012
- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- 37 citationsA comparative dosimetric analysis of virtual stereotactic body radiotherapy to high-dose-rate monotherapy for intermediate-risk prostate cancer.Daniel E. Spratt, Lawrence M. Scala, Michael R. Folkert, Laszlo Voros, Gil'ad N. Cohen
Brachytherapy. 2013-09-01 - 25 citationsIntraoperative high-dose-rate radiotherapy in the management of locoregionally recurrent head and neck cancer.L. Matthew Scala, Kenneth S. Hu, Mark L. Urken, Adam S. Jacobson, Mark S. Persky
Head & Neck. 2013-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: